YIDU TECH's Affiliate Secures Contract for Tianjin Cancer Hospital's Intelligent Clinical Research Platform

Stock News
05/21

YIDU TECH (02158) announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has recently been awarded the contract for the Intelligent Clinical Research Integrated Platform Construction Project at Tianjin Cancer Hospital. The total project value is approximately RMB 7.39 million.

YIDU TECH is a core driver of intelligent transformation within China's healthcare system. The company deeply empowers the entire industry chain encompassing "healthcare, pharmaceuticals, insurance, and patients" through intelligent decision-making, aiming to make precision medicine accessible to everyone.

By simulating clinical decision-making logic, using real disease progression as training data, and undergoing continuous real-world validation, the company has developed an "AI that truly understands disease." This provides measurable value to key segments of the medical ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the distance from molecule to patient, enabling patients to access more affordable precision diagnosis and treatment, and providing public health systems with more scientific support.

YIDU TECH leverages its proprietary, system-level intelligence to create a more resilient, compassionate, inclusive, and efficient future for healthcare.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10